PurePharma X3

PurePharma has just launched the first self-test kit that enables you to find out which nutrients you lack! This is an exciting new product that is especially important for those who take our health very seriously, especially athletes performing at the top of their game.


PurePharma X3 is the first self-test kit that allows you to assess your levels of omega-3 fatty acids, omega-6 fatty acids and vitamin D. Exposure to trans fats and low-grade chronic inflammation are also evaluated.

What makes this product even better is that you will receive a thorough report containing personal recommendations on how to change your diet or lifestyle to improve overall health.

Many experts agree that a significant number of people are lacking omega-3 fatty acids and vitamin D, two nutrients that play an essential role in general health and well-being. By developing the new X3 Test, PurePharma offers you not only a tool to check the levels of these nutrients, but also a way to better understand your general health condition and how you can improve it.

Oliver Amdrup, Co-Founder of PurePharma, explains: “PurePharma’s mission is above all to improve people’s health. That’s why we want to make sure people only take supplements when they need it. X3 Test simplifies and improves the way nutrient testing is done at the moment, by offering personalized results and guidance.”

Compared to similar health tests on the market, PurePharma X3 testing procedure is so simple that you can actually take the test at home, without having to visit a doctor’s office for a blood draw. All of the needed materials are included in the test kit, together with a set of instructions meant to easily guide you through the process. After 4-6 weeks, you will receive the test results by email, along with a thorough report including personalised recommendations on how to improve your health by consuming those food products that may compensate for your nutrient deficiencies.

To order find out more or to order, contact REBEL Elite Fitness.

This Post Has 0 Comments

Leave A Reply